• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EB 病毒相关 B 细胞淋巴瘤:发病机制与临床转归。

Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.

机构信息

Department of Microbiology and Tumor Virology Program, Abramson, Comprehensive Cancer Center, University of Pennsylvania Medical School, Philadelphia, Pennsylvania 19104, USA.

出版信息

Clin Cancer Res. 2011 May 15;17(10):3056-63. doi: 10.1158/1078-0432.CCR-10-2578. Epub 2011 Mar 3.

DOI:10.1158/1078-0432.CCR-10-2578
PMID:21372216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4287361/
Abstract

Epstein-Barr virus (EBV) is a ubiquitous human γ-herpesvirus that establishes a life-long asymptomatic infection in immunocompetent hosts. It is also found to be frequently associated with a broad spectrum of B-cell lymphomas predominantly seen in immunodeficient patients. Despite many resemblances, these EBV-linked lymphoproliferative disorders display heterogeneity at the clinical and the molecular level. Moreover, EBV-associated lymphoproliferative diseases differ in their differential expression patterns of the EBV-encoded latent antigens, which are directly related to their interactions with the host. EBV-driven primary B-cell immortalization is linked to the cooperative functions of these latent proteins, which are critical for perturbing many important cell-signaling pathways maintaining B-cell proliferation. Additionally, it is used as a surrogate model to explore the underlying mechanisms involved in the development of B-cell neoplasms. Recent discoveries have revealed that a number of sophisticated mechanisms are exploited by EBV during cancer progression. This finding will be instrumental in the design of novel approaches for therapeutic interventions against EBV-associated B-cell lymphomas. This review limits the discussion to the biology and pathogenesis of EBV-associated B-cell lymphomas and the related clinical implications.

摘要

EB 病毒(EBV)是一种广泛存在的人类γ疱疹病毒,在免疫功能正常的宿主中建立终身无症状感染。它也经常与广泛的 B 细胞淋巴瘤相关,主要见于免疫功能低下的患者。尽管有许多相似之处,但这些 EBV 相关的淋巴增殖性疾病在临床和分子水平上表现出异质性。此外,EBV 相关的淋巴增殖性疾病在 EBV 编码的潜伏抗原的表达模式上存在差异,这与它们与宿主的相互作用直接相关。EBV 驱动的原发性 B 细胞永生化与这些潜伏蛋白的协同功能有关,这些功能对于扰乱维持 B 细胞增殖的许多重要细胞信号通路至关重要。此外,它被用作探索 B 细胞肿瘤发生中涉及的潜在机制的替代模型。最近的发现表明,EBV 在癌症进展过程中利用了许多复杂的机制。这一发现将有助于设计针对 EBV 相关 B 细胞淋巴瘤的新型治疗干预方法。本文的讨论仅限于 EBV 相关 B 细胞淋巴瘤的生物学和发病机制及其相关的临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3515/4287361/9ca70c55a9c1/nihms276419f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3515/4287361/9ca70c55a9c1/nihms276419f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3515/4287361/9ca70c55a9c1/nihms276419f1.jpg

相似文献

1
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.EB 病毒相关 B 细胞淋巴瘤:发病机制与临床转归。
Clin Cancer Res. 2011 May 15;17(10):3056-63. doi: 10.1158/1078-0432.CCR-10-2578. Epub 2011 Mar 3.
2
B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.B淋巴细胞与爱泼斯坦-巴尔病毒:移植后淋巴细胞增生性疾病的教训
Autoimmun Rev. 2007 Dec;7(2):96-101. doi: 10.1016/j.autrev.2007.02.012. Epub 2007 Mar 26.
3
An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.EBNA3C 缺失型 Epstein-Barr 病毒 (EBV) 突变体能在脐血人源化小鼠模型中导致潜伏期较长的 B 细胞淋巴瘤。
PLoS Pathog. 2018 Aug 20;14(8):e1007221. doi: 10.1371/journal.ppat.1007221. eCollection 2018 Aug.
4
Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.口腔非霍奇金淋巴瘤中EB病毒的检测:一项免疫细胞化学和原位杂交研究
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):184-93. doi: 10.1067/moe.2001.116155.
5
Epstein-Barr virus (EBV) and lymphomagenesis.爱泼斯坦-巴尔病毒(EBV)与淋巴瘤发生
Front Biosci. 2002 Feb 1;7:e58-65. doi: 10.2741/A907.
6
Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.EBV 癌基因 LMP-1 下调 BLIMP1α,破坏浆细胞分化程序,防止 B 细胞中病毒复制:对 EBV 相关 B 细胞淋巴瘤发病机制的影响。
Blood. 2011 Jun 2;117(22):5907-17. doi: 10.1182/blood-2010-09-307710. Epub 2011 Mar 16.
7
The viral and cellular microRNA targetome in lymphoblastoid cell lines.淋巴母细胞系中的病毒和细胞 microRNA 靶标组。
PLoS Pathog. 2012 Jan;8(1):e1002484. doi: 10.1371/journal.ppat.1002484. Epub 2012 Jan 26.
8
Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus.EB 病毒诱导 B 细胞肿瘤发生的机制。
J Virol. 2019 Jun 14;93(13). doi: 10.1128/JVI.00238-19. Print 2019 Jul 1.
9
EBV-Encoded Latent Genes.EBV 编码的潜伏基因。
Adv Exp Med Biol. 2018;1045:377-394. doi: 10.1007/978-981-10-7230-7_17.
10
The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.EB 病毒 BHLF1 基因座促进病毒潜伏期和 B 细胞永生化。
J Virol. 2020 Aug 17;94(17). doi: 10.1128/JVI.01215-20.

引用本文的文献

1
Immune Deficiency/Dysregulation-Associated EBV-Positive Classic Hodgkin Lymphoma.免疫缺陷/失调相关的EB病毒阳性经典型霍奇金淋巴瘤
Cancers (Basel). 2025 Apr 25;17(9):1433. doi: 10.3390/cancers17091433.
2
The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.针对多发性硬化症中潜伏性和裂解性爱泼斯坦-巴尔病毒感染的理由。
Brain. 2025 Sep 3;148(9):3057-3071. doi: 10.1093/brain/awaf170.
3
A modified multiple cross displacement amplification linked with a gold nanoparticle biosensor for the detection of Epstein-Barr virus in clinical applications.

本文引用的文献

1
Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.EB 病毒核抗原 3C 通过稳定和增强细胞周期蛋白 D1 的功能促进 G1-S 期转换。
PLoS Pathog. 2011 Feb 10;7(2):e1001275. doi: 10.1371/journal.ppat.1001275.
2
EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.EBNA3C 通过与生长抑制因子家族蛋白 4 和 5 的相互作用来减弱 p53 的功能。
J Virol. 2011 Mar;85(5):2079-88. doi: 10.1128/JVI.02279-10. Epub 2010 Dec 22.
3
Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.
一种与金纳米颗粒生物传感器联用的改良多重交叉置换扩增技术,用于临床应用中检测爱泼斯坦-巴尔病毒。
Front Microbiol. 2023 Oct 11;14:1268572. doi: 10.3389/fmicb.2023.1268572. eCollection 2023.
4
Primary Diffuse Large B-Cell Lymphoma of the Rectum in a Non-Immunosuppressed Patient with Ulcerative Colitis.一名非免疫抑制的溃疡性结肠炎患者的原发性直肠弥漫性大B细胞淋巴瘤
GE Port J Gastroenterol. 2022 Mar 18;30(4):305-310. doi: 10.1159/000522044. eCollection 2023 Aug.
5
Vaccination against Epstein-Barr Latent Membrane Protein 1 Protects against an Epstein-Barr Virus-Associated B Cell Model of Lymphoma.针对爱泼斯坦-巴尔病毒潜伏膜蛋白1进行疫苗接种可预防与爱泼斯坦-巴尔病毒相关的淋巴瘤B细胞模型。
Biology (Basel). 2023 Jul 11;12(7):983. doi: 10.3390/biology12070983.
6
Malignancy and viral infections in Sub-Saharan Africa: A review.撒哈拉以南非洲的恶性肿瘤与病毒感染:综述
Front Virol. 2023;3. doi: 10.3389/fviro.2023.1103737. Epub 2023 Mar 6.
7
A rare case of Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified, in a patient with ulcerative colitis.一例罕见的溃疡性结肠炎相关的 EBV 阳性弥漫性大 B 细胞淋巴瘤,非特指型。
Clin J Gastroenterol. 2023 Aug;16(4):543-549. doi: 10.1007/s12328-023-01811-z. Epub 2023 May 19.
8
Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies.比较分析 EBV 相关恶性肿瘤中针对 EBV 蛋白组的体液免疫反应。
Cancer Epidemiol Biomarkers Prev. 2023 May 1;32(5):687-696. doi: 10.1158/1055-9965.EPI-22-0452.
9
EBV-associated diseases: Current therapeutics and emerging technologies.EBV 相关疾病:当前的治疗方法和新兴技术。
Front Immunol. 2022 Oct 27;13:1059133. doi: 10.3389/fimmu.2022.1059133. eCollection 2022.
10
Enhancing B-Cell Malignancies-On Repurposing Enhancer Activity towards Cancer.增强B细胞恶性肿瘤——关于将增强子活性重新用于癌症治疗
Cancers (Basel). 2021 Jun 29;13(13):3270. doi: 10.3390/cancers13133270.
EBV 核抗原 3 蛋白在宿主基因表达和表观遗传染色质修饰的操纵中的广泛合作。
PLoS One. 2010 Nov 15;5(11):e13979. doi: 10.1371/journal.pone.0013979.
4
Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.肿瘤病毒与癌症生物学:调控信号通路的治疗干预策略。
Cancer Biol Ther. 2010 Nov 15;10(10):961-78. doi: 10.4161/cbt.10.10.13923.
5
Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1).全基因组分析 Epstein-Barr 病毒核抗原 1(EBNA1)与宿主染色体结合的位点。
Virol J. 2010 Oct 7;7:262. doi: 10.1186/1743-422X-7-262.
6
Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.CD40 及其病毒模拟物潜伏膜蛋白 1 对 B 淋巴细胞的差异调节。
Immunol Rev. 2010 Sep;237(1):226-48. doi: 10.1111/j.1600-065X.2010.00932.x.
7
Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies.EB 病毒核抗原 1 劫持宿主激酶 CK2 以破坏 PML 核体。
J Virol. 2010 Nov;84(21):11113-23. doi: 10.1128/JVI.01183-10. Epub 2010 Aug 18.
8
Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.人类 B 淋巴细胞与 Epstein-Barr 病毒(EBV)的相互作用。
Biochem Biophys Res Commun. 2010 May 21;396(1):67-73. doi: 10.1016/j.bbrc.2010.02.146.
9
Discovery of selective inhibitors against EBNA1 via high throughput in silico virtual screening.通过高通量计算机虚拟筛选发现 EBNA1 的选择性抑制剂。
PLoS One. 2010 Apr 12;5(4):e10126. doi: 10.1371/journal.pone.0010126.
10
Role of EBERs in the pathogenesis of EBV infection.EBV 感染发病机制中 EBERs 的作用。
Adv Cancer Res. 2010;107:119-36. doi: 10.1016/S0065-230X(10)07004-1.